Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |